您的位置: 首页 > 农业专利 > 详情页

CLOSANTEL IN COMBINATION WITH TEMOZOLOMIDE FOR USE IN THE TREATMENT OF A CANCER IN WHICH IS THYMINE DNA GLYCOSYLASE EXPRESSED
专利权人:
Institute For Cancer Research D/b/a The Research Institute of Fox Chase Cancer Center
发明人:
申请号:
EP14847598.1
公开号:
EP3052655B1
申请日:
2014.09.30
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The invention provides compositions, kits, and methods for inducing growth arrest, differentiation, or senescence of cancer cells that express thymine DNA glycosylase, and treating the cancer accordingly. The methods comprise inhibiting expression or biologic activity of thymine DNA glycosylase in cancer cells. Inhibition of thymine DNA glycosylase in cancer cells may induce the cells to revert to a healthy, non-cancerous phenotype and/or may induce the cells to senesce. Cancer cells include melanoma, lung, prostate, pancreatic, ovarian, brain, colon, recto-sigmoid colon, and breast cancer cells.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充